Literature DB >> 16581163

Long-term immunity in young adults after a single dose of inactivated Hepatitis A vaccines.

Nadav Orr1, Eyal Klement, David Gillis, Tamar Sela, Raid Kayouf, Estela Derazne, Itamar Grotto, Ran Balicer, Michael Huerta, Lisa Aviram, Ruhama Ambar, Yoram Epstein, Yuval Heled, Dani Cohen.   

Abstract

We evaluated in a prospective study the immune response of naïve subjects to a single dose of inactivated Hepatitis A vaccine. Ninety-seven percent of the vaccinees sero-converted 1 month after vaccination and 93% were still positive 2 years later. All of the vaccinees had a strong booster response 2 years after the single dose. Avaxim was more immunogenic than Vaqta for the primary dose (p = 0.01 for sero-positivity, p<0.001 for antibody level) but no differences were found after boosting with Avaxim. Performance of intense physical activity during the first month after a single vaccine dose was associated with lower antibody levels (p = 0.004). This study indicates that a single dose of inactivated HAV vaccine elicits protective immune memory for at least 2 years.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16581163     DOI: 10.1016/j.vaccine.2006.03.010

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

Review 1.  Hepatitis A immunisation in persons not previously exposed to hepatitis A.

Authors:  Greg J Irving; John Holden; Rongrong Yang; Daniel Pope
Journal:  Cochrane Database Syst Rev       Date:  2019-12-17

Review 2.  Vaccination policy in Korean armed forces: current status and future challenge.

Authors:  Jung Yeon Heo; Kang-Won Choe; Chang-Gyo Yoon; Hye Won Jeong; Woo Joo Kim; Hee Jin Cheong
Journal:  J Korean Med Sci       Date:  2015-03-19       Impact factor: 2.153

3.  Secular trends of chickenpox among military population in Israel in relation to introduction of varicella zoster vaccine 1979-2010.

Authors:  Daniel Mimouni; Hagai Levine; Anat Tzurel Ferber; Inbal Rajuan-Galor; Michael Huerta-Hartal
Journal:  Hum Vaccin Immunother       Date:  2013-02-14       Impact factor: 3.452

Review 4.  Hepatitis A immunisation in persons not previously exposed to hepatitis A.

Authors:  Greg J Irving; John Holden; Rongrong Yang; Daniel Pope
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

Review 5.  Wanted, dead or alive: new viral vaccines.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Antiviral Res       Date:  2009-09-04       Impact factor: 5.970

6.  A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice.

Authors:  Kui Xiang; Yuri Kusov; Guan Ying; Wang Yan; Yi Shan; Wu Jinyuan; Yin Na; Zhou Yan; Li Hongjun; Sun Maosheng
Journal:  Viruses       Date:  2017-09-15       Impact factor: 5.048

7.  Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.

Authors:  Christien Rondaan; Victoria Furer; Marloes W Heijstek; Nancy Agmon-Levin; Marc Bijl; Ferdinand C Breedveld; Raffaele D'Amelio; Maxime Dougados; Meliha C Kapetanovic; Jacob M van Laar; Annette Ladefoged de Thurah; Robert Landewé; Anna Molto; Ulf Müller-Ladner; Karen Schreiber; Leo Smolar; Jim Walker; Klaus Warnatz; Nico M Wulffraat; Sander van Assen; Ori Elkayam
Journal:  RMD Open       Date:  2019-09-09

8.  Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina.

Authors:  Carlos Espul; Laura Benedetti; Héctor Cuello; Guy Houillon; Anvar Rasuli
Journal:  Hepat Med       Date:  2012-08-28

9.  Reappraisal of the Immunogenicity and Safety of Three Hepatitis A Vaccines in Adolescents.

Authors:  Seo Hee Yoon; Han Wool Kim; Jong Gyun Ahn; In Tae Kim; Jong-Hyun Kim; Kyoung Ae Kong; Kyung-Hyo Kim
Journal:  J Korean Med Sci       Date:  2015-12-24       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.